Window Trial to Evaluate Molecular Response to PI3K Inhibition With Copanlisib in r/r Adult B-cell ALL
Clinical trial NCT04803123 · TERMINATED
Trial details
- NCT number
- NCT04803123
- Sponsor
- Dorothy Sipkins, MD, PhD
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-21
- Primary completion
- 2023-04-03
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.